Iron Deficiency Diagnosis and Treatment

Diagnosis and Assessment

Transferrin saturation (TSAT) is calculated as: (serum iron concentration/TIBC) × 100, and a TSAT of less than 16% in adults is often used to confirm iron deficiency, according to the Centers for Disease Control and Prevention (CDC) and the National Kidney Foundation 1, 2
Low TSAT with normal ferritin may indicate functional iron deficiency rather than absolute iron deficiency, as suggested by the National Kidney Foundation 2
TSAT has significant diurnal variation, and samples should be obtained at consistent times, with greater day-to-day variation than ferritin, according to the CDC and the National Kidney Foundation 1, 2
Ferritin is an acute-phase reactant and may be falsely elevated in inflammation, consider other markers like soluble transferrin receptor which is less affected by inflammation, with high Total Iron Binding Capacity (TIBC) and low ferritin levels indicative of iron deficiency 3, 1

Consider IV iron if TSAT <20% even with normal ferritin, and evaluate for GI causes of iron deficiency, especially if anemia is present, as suggested by the National Kidney Foundation and the European Society of Gastrointestinal Endoscopy 2, 4
In functional iron deficiency, serial ferritin levels decrease during therapy, whereas in inflammatory block, there is often an abrupt increase in ferritin with a sudden drop in TSAT, according to the National Kidney Foundation 2
Iron deficiency in heart failure patients is defined as ferritin levels below a certain threshold or ferritin levels within a certain range with transferrin saturation below a certain percentage, according to the American Heart Association 5
Targeting higher ferritin levels and transferrin saturation is recommended, with IV iron particularly beneficial in CKD patients who often have functional iron deficiency due to hepcidin dysregulation, as stated by the National Kidney Foundation and the American Society of Nephrology 6, 2

The recommended dosage for oral iron supplementation is 100-200 mg elemental iron daily, in divided doses, for patients with iron deficiency, according to the American Journal of Kidney Diseases guidelines and the European Society of Gastroenterology 3, 7
Take iron supplements on an empty stomach, 1 hour before or 2 hours after meals, and administer 200 mg of elemental iron daily in 2-3 divided doses in adults, with 500 mg of vitamin C to improve absorption, as recommended by the American Journal of Kidney Diseases guidelines and the Clinical Gastroenterology and Hepatology guidelines 8, 2
Avoid simultaneous intake of calcium supplements with iron, and separate the administration of iron and antacids containing aluminum or magnesium by at least 2 hours, as recommended by the Clinical Gastroenterology and Hepatology guidelines 8

Hemoglobin concentration and red cell indices should be monitored at three-month intervals for one year after normalization, according to the European Society of Gastroenterology 7
Recheck ferritin and complete blood count in 3 months, and then again after one year if levels remain stable, with iron supplementation resumed if ferritin level drops below 30 ng/mL on follow-up testing, or if symptoms of iron deficiency develop with declining ferritin levels, as recommended by the American Gastroenterological Association 7
Iron parameters should not be evaluated within 4 weeks of IV iron administration as circulating iron can interfere with the assay, according to the American Journal of Hematology 9

Target ferritin levels:
Target parameters for iron management include TSAT <50% and ferritin <500 ng/mL, according to the American Journal of Kidney Diseases guidelines 2

Transferrin Saturation (TSAT) values >50% suggest potential iron overload, and Serum Ferritin values >800 ng/mL also suggest potential iron overload, with immediate discontinuation of all iron supplementation when iron overload is identified, as recommended by the American Journal of Kidney Diseases 2
Iron parameters should be checked every 3 months during treatment to prevent iron overload, according to the American Journal of Kidney Diseases guidelines 2

IV iron is indicated when patients do not tolerate oral iron, ferritin levels do not improve with adequate trial of oral iron, or patients have a condition in which oral iron is not likely to be absorbed, with IV iron producing more rapid hemoglobin increase compared to oral iron in advanced CKD, according to the American Journal of Kidney Diseases guidelines and the Clinical Gastroenterology and Hepatology guidelines 11, 8
Choose IV iron formulations that can replace iron deficits with 1-2 infusions rather than those requiring multiple infusions, with all IV iron formulations having similar risk profiles, and true anaphylaxis being rare, but monitor for infusion reactions, as recommended by the Clinical Gastroenterology and Hepatology guidelines 8